FIBROGEN INC — Director's Dealing 2023

Jun 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-06-07

Reporting Person: Wettig Thane (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-07	Common Stock	S	472	$17.0356	Disposed	112681	Direct
2023-06-07	Common Stock	S	1286	$17.0377	Disposed	111395	Direct

Footnotes

F1: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F2: Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.